NCT05542836

Brief Summary

This is a 2-year follow-up study from EVeRLAST which objective was to determine whether expedited resumption of postoperative activity levels is non-inferior to standard activity restrictions with respect to short-term anatomic prolapse outcomes. The preliminary data from the original study suggest expedited instructions are non-inferior. We hypothesize this effect continues at the 2-year postoperative mark and patients continue to have non-inferior outcomes after prolapse surgery when compared to standard postoperative activity restrictions. Participants from the original EVeRLAST will be approached to assess their interest in participating in the 2-year follow up study. We will be collecting objective and subjective data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2022

Completed
14 days until next milestone

Study Start

First participant enrolled

September 30, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 27, 2023

Completed
Last Updated

December 6, 2024

Status Verified

February 1, 2024

Enrollment Period

12 months

First QC Date

September 13, 2022

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prolapse symptoms measured by the Pelvic Organ Prolapse Distress Inventory (POPDI)

    The POPDI results in scores ranging from 0 to 300; higher scores indicate greater symptom distress.

    2 year +/- 1 month following the initial prolapse surgery

Secondary Outcomes (6)

  • Functional activity measured by the Activities Assessment Scale (AAS)

    2 year +/- 1 month following the initial prolapse surgery

  • Physical function assessed by the Global Impression of Improvement

    2 year +/- 1 month following the initial prolapse surgery

  • Physical function assessed by the Patient Reported Outcomes Measurement Information System (PROMIS) Global Health Short Form

    2 year +/- 1 month following the initial prolapse surgery

  • Pelvic floor symptom severity measured by the Pelvic Floor Distress Index (PFDI-20)

    2 year +/- 1 month following the initial prolapse surgery

  • Physical function as measured by a 2-minute walk test (2MWT)

    2 years +/- 1 month following the initial prolapse surgery

  • +1 more secondary outcomes

Study Arms (2)

Expedited postoperative activity instructions

Ad lib postoperative activity and return to work recommendations

Behavioral: Expedited postoperative activity instructions

Standard postoperative activity restrictions

Standard conservative postoperative activity and return to work recommendations

Behavioral: Standard postoperative activity restructions

Interventions

Ad lib postoperative activity and return to work recommendations

Expedited postoperative activity instructions

Standard conservative postoperative activity and return to work recommendations

Standard postoperative activity restrictions

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Eligible subjects include all patients from the prior EVeRLAST study.

You may qualify if:

  • Patient who were previously enrolled in the initial EVeRLAST study.

You may not qualify if:

  • Enrollment in another research study of pelvic organ prolapse.
  • Any patients who underwent further surgery in the 3 months following their prolapse surgery or patients who underwent unanticipated treatment which would result in prolonged inactivity (such as a cancer diagnosis) 3 months following their prolapse surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27707, United States

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2022

First Posted

September 16, 2022

Study Start

September 30, 2022

Primary Completion

September 27, 2023

Study Completion

September 27, 2023

Last Updated

December 6, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations